aTyr Pharma, Inc. announced its expected inclusion in the Russell 2000® Index and the broad market Russell 3000® Index. This change will be effective after the U.S. market close on June 27, 2025, as part of the 2025 Russell U.S. Indexes annual reconstitution.
Membership in the Russell Indexes lasts for one year and results in automatic inclusion in appropriate growth and value style indexes. FTSE Russell determines membership primarily by objective, market-capitalization rankings and style attributes.
The Russell Indexes are widely used by investment managers and institutional managers for index funds and as benchmarks for active investment strategies. This inclusion is expected to increase the company's exposure to a broader investment community.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.